<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">166</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2016-15-3-23-28</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>HEMATOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГЕМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Echocardiographic assessment of the state of the heart in children with ß-thalassemia</article-title><trans-title-group xml:lang="ru"><trans-title>Эхокардиографическая оценка состояния сердца у детей с ß-талассемией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nikolaeva</surname><given-names>Galina N.</given-names></name><name xml:lang="ru"><surname>Николаева</surname><given-names>Галина Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>galina-2020@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sugak</surname><given-names>Anna B.</given-names></name><name xml:lang="ru"><surname>Сугак</surname><given-names>Анна Борисовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>sugak08@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Feoktistova</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Феоктистова</surname><given-names>Елена Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>9433672@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kurov</surname><given-names>Il'ya O.</given-names></name><name xml:lang="ru"><surname>Куров</surname><given-names>Илья Олегович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kurov@phystech.edu</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitry Rogachev Federal Research Centre of Paediatric Haematology, Oncology and Immunology, Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Moscow Institute of Physics and Technology (State University)</institution></aff><aff><institution xml:lang="ru">Московский физико-технический институт (государственный университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-09-19" publication-format="electronic"><day>19</day><month>09</month><year>2016</year></pub-date><volume>15</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>23</fpage><lpage>28</lpage><history><date date-type="received" iso-8601-date="2018-09-19"><day>19</day><month>09</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/166">https://hemoncim.com/jour/article/view/166</self-uri><abstract xml:lang="en"><p>The main causes of the development of thalassemia-associated cardiomyopathy are volume overload of the heart resulting from adaptation to chronic anaemia and iron toxic effects on the myocardium resulting from replacement blood transfusion therapy. In order to reveal left ventricle (LV) dysfunction echocardiography (Echo-CG) with examination of the mitral valve fibrous ring (MV FR) motion was performed in the tissue Doppler mode in 50 patients with ß-thalassemia and 47 conditionally healthy children aged 2 to 16 years. Patients with ß-thalassemia as compared with the control group had a significantly larger LV diameter, higher LV volume indices, LV myocardial mass index, left atrial diameter, cardiac index, transmitral flow velocity, MV FR motion diastolic velocities and a ratio between LV early diastolic filling velocity and MV FR motion early diastolic velocity, significantly smaller LV ejection fraction (p &lt; 0.5). LV wall thickness, LV myocardial mass, heart rate, LV stroke volume, LV minute volume, ratios between transmitral flow velocities, MV FR motion systolic velocities did not differ among groups. In patients with ß-thalassemia, echo-CG permits to diagnose dilatation, hypertrophy and hyperkinesis of LV associated with cardiac volume overload. The hyperkinetic status might mask early signs of diastolic dysfunction. For diagnosing early signs of systolic dysfunction it is necessary to develop reference values of LV ejection fraction for patients with ß-thalassemia.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>ß-талассемия</kwd><kwd>кардиомиопатия</kwd><kwd>тканевой допплер</kwd><kwd>эхокардиография</kwd><kwd>children</kwd><kwd>ß-thalassemia</kwd><kwd>cardiomyopathy</kwd><kwd>tissue Doppler imaging</kwd><kwd>echocardiography</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D, et al. Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail. 2010;3(3):451-8</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, et al. Cardiovascular function and treatment in ß-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128(3):281-308.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Taksande A, Prabhu S, Venkatesh S. Cardiovascular aspect of Beta-Thalassemia. CardiovascHematol Agents Med Chem. 2012;10(1):25-30.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Wood JC. Cardiac iron across different transfusion-dependent diseases. Blood Rev. 2008;22(Suppl. 2):S14-21.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Fabio G, Minonzio F, Delbini P, Bianchi A, Cappellini MD. Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH). Blood. 2007;109(1):362-4.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y. Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol. 2010;56(13):1001-12.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Rodrigues A, Guimaraes-Filho FV, Braga JC, Rodrigues CS, Waib P, Fabron-Junior A, et al. Echocardiography in thalassemic patients on blood transfusions and chelation without heart failure. Arq Bras Cardiol. 2013;100(1):75-81.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the clinical management of thalassaemia. 2nd revised edition. Nicosia (CY): Thalassaemia International Federation, 2008.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Du Bois D, Du Bois EF. A formula to estimate the approximatesurfacearea if height and weight be known. Arch Intern Med. 1916;(17):863-71.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010;23(5):465-95; quiz 576-7.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976;37:7-11.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984 Dec;4(6):1222-30.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol. 1995;76(10):699-701.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Сугак АБ. Ультразвуковая диагностика поражения сердечно-сосудистой системы у детей с ревматическми болезнями. Автореф. дисс.. докт. мед. наук. М., 2012. / Sugak AB. Ul'trazvukovaya diagnostika porazheniya serdechno-sosudistoi sistemy u detei s revmaticheskmi boleznyami. Avtoref. diss.. dokt. med. nauk. Moscow, 2012. (In Russian).</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009 Feb;22(2):107-33. doi: 10.1016/j.echo.2008.11.023.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Abbas AA, Najeb B, Abdulhussein A, Jassim JH, Falih MA, Jubiaer H, et al. Echocardiographic parameters of left ventricle systolic and diastolic function in patients with ß-thalassemia major. The Iraqi Postgraduate Med J. 2012;11(4):562-8.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hyder SN, Kazmi U, Malik A. An echocardiographic evaluation of left ventricular function in patients with thalassemia major. J Pak Med Stud. 2013;3(Issue 1):10-5.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Noori NM, Mehralizadeh S. Echocardiographic evaluation of systolic and diastolic heart function in patients suffering from beta-thalassemia major aged 5-10 years at the Zahedan Research Center for Children and Adolescent Health. Anadolu Kardiyol Derg. 2010;10(2):150-3.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Papadopoulou-Legbelou K, Varlamis SG, Athanassiou-Metaxa M, Karamperis S, Malaka-Zafiriou A. Full resting echocardiographic study of left ventricle in children with ß-thalassemia major. Kardiologia. 2009;2-3:132-8.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ragab SM, Fathy WM, El-Aziz WF, Helal RT. The diagnostic value of pulsed wave Tissue Doppler Imaging in asymptomatic beta-thalassemia major children and young adults; relation to chemical biomarkers of left ventricular function and iron overload. Mediterr J Hematol Infect Dis. 2015;7(1):e2015051.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Yildirim AT, Oymak Y, Yaman Y, Mese T, Bayraktaroglu S, Aydinok Y, et al. Examination of echocardiographic parameters for the early diagnosis of cardiac dysfunction in beta thalassemia major patients. Medical Science and Discovery. 2014;1(2):35-43.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Stakos DA, Margaritis D, Tziakas DN, Kostianidis I, Chalikias GK, Tsatalas K, et al. Cardiovascular involvement in patients with ß-thalassemia major without cardiac iron overload. Internat J Cardiol. 2009;134(2):207-11.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Aessopos A, Deftereos S, Tsironi M, Karabatsos F, Yousef J, Fragodimitri C, et al. Predictive echo-Doppler indices of left ventricular impairment in ß-thalassemic patients. Ann Hematol. 2007;86(6):429-34.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Veglio F, Melchio R, Rabbia F, Molino P, Genova GC, Martini G, et al. Blood pressure and heart rate in young thalassemia major patients. Am J Hypertens. 1998;11(5):539-47.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Wood JC, Enriques C, Ghugre N, Otto-Duessel M, Aguilar M, Nelson MD, et al. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann NY Acad Sci. 2005;1054:386-95.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Balci YI, Gurses D. Detection of early cardiac dysfunction in patients with ß-thalassemia trait by tissue doppler echocardiography. Pediatr Hematol Oncol. 2011;28(6):486-96.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Aypar E, Alehan D, Hazirolan T, Gumrük F. The efficacy of tissue Doppler imaging in predicting myocardial iron load in patients with beta-thalassemia major: correlation with T2* cardiovascular magnetic resonance. Int J Cardiovasc Imaging. 2010;26(4):413-21.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Dokainish H, Sengupta R, Pillai M, Bobek J, Lakkis N. Assessment of left ventricular systolic function using echocardiography in patients with preserved ejection fraction and elevated diastolic pressure. Am J Cardiol. 2008;101(12):1766-71.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000;102(15):1788-94.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Parale GP, Pawar SS, Tapare VS. Assessment of LV diastolic function in patients with beta-thalassemia major with special reference to E/Eann ratio. J Pediatr Hematol Oncol. 2009;31(1):69-73.</mixed-citation></ref></ref-list></back></article>
